On Dec. 4. 2019, US-based Nanomix announced that the company had received CE Mark for its S1 Assay for the rapid, simultaneous detection and quantification of lactate, procalcitonin, and C-reactive protein from human plasma specimens.

Designed for use with Nanomix elab analyser, the CE-marked S1 Assay Panel will aid in rapid, simultaneous detection and quantification of lactate (LAC), procalcitonin(PCT) and C-reactive protein (CRP) in human plasma specimens.

It is challenging to detect serious infections from clinical symptoms and delay in treatment raises the risk of death from sepsis. The S1 Assay is claimed to be a simple, accurate and cost-effective panel that runs on the eLab analyser, intended to provide results of LAC, PCT and CRP within 11 minutes. It provides critical diagnostic information to physicians to offer appropriate decision-making treatments during diagnosis.

The Nanomix eLab analyser, suitable for use within or outside traditional laboratory settings, is a microfluidic-based handheld system, single-use consumable along with an electrochemical sensor for automated and simultaneous detection of several analytes.

In addition to Bluetooth and USB connectivity facilities, the eLab analyser features touchscreen graphical interface with a built-in barcode scanner.